Carbidopa-Levodopa 25mg-100mg CR

Carbidopa-Levodopa 25mg-100mg CR Tablets – Complete Product Description

Carbidopa-Levodopa 25mg-100mg CR (Controlled Release) is a prescription medication used for the long-term management of Parkinson’s disease and Parkinsonian syndromes. This controlled-release formulation contains 25mg of Carbidopa and 100mg of Levodopa, designed to provide a more gradual release of medication over time, helping maintain stable dopamine levels and improve symptom control throughout the day.

Parkinson’s disease occurs when dopamine-producing nerve cells in the brain gradually decline. This dopamine deficiency can result in tremors, muscle stiffness, slow movement, balance difficulties, and impaired coordination. Carbidopa-Levodopa 25mg-100mg CR helps restore dopamine activity, supporting improved mobility and daily functioning.

Uses of Carbidopa-Levodopa 25mg-100mg CR

Carbidopa-Levodopa 25mg-100mg CR is commonly prescribed for:

• Parkinson’s disease
• Parkinsonian syndromes
• Management of motor fluctuations
• Reduction of “wearing-off” symptoms between doses
• Treatment of tremors and muscle rigidity
• Improvement of mobility and movement control

How Carbidopa-Levodopa 25mg-100mg CR Works

Levodopa is converted into dopamine after crossing into the brain, helping replenish the neurotransmitter that is deficient in Parkinson’s disease. Increased dopamine levels improve communication between nerve cells responsible for movement and coordination.

Carbidopa prevents the premature breakdown of Levodopa before it reaches the brain. The controlled-release (CR) formulation gradually releases medication over an extended period, helping provide longer-lasting symptom control and reducing fluctuations in dopamine levels.

Benefits of Carbidopa-Levodopa 25mg-100mg CR

• Provides extended symptom control
• Helps reduce “off” periods between doses
• Supports smoother movement throughout the day
• May reduce muscle stiffness and rigidity
• Improves walking, balance, and coordination
• Enhances daily activities and quality of life
• Controlled-release formulation offers sustained medication delivery

Dosage and Administration

Carbidopa-Levodopa 25mg-100mg CR should only be used according to your healthcare provider’s instructions. Dosage depends on individual treatment requirements, disease progression, and response to therapy.

Controlled-release tablets should be swallowed whole unless otherwise directed by a healthcare professional. Breaking, crushing, or chewing the tablet may alter the extended-release properties of the medication.

Patients should take the medication consistently as prescribed and attend regular follow-up appointments for dosage evaluation and monitoring.

Possible Side Effects

Like all medications, Carbidopa-Levodopa 25mg-100mg CR may cause side effects in some patients.

• Nausea
• Dizziness
• Drowsiness
• Headache
• Dry mouth
• Constipation
• Sleep disturbances
• Low blood pressure upon standing
• Involuntary movements (dyskinesia)

Contact your healthcare provider immediately if you experience severe side effects such as hallucinations, chest pain, severe allergic reactions, confusion, or sudden behavioral changes.

Warnings and Precautions

• Use only under medical supervision.
• Inform your physician about all medications and supplements you are taking.
• Do not discontinue treatment abruptly.
• Patients with glaucoma, cardiovascular disease, or psychiatric disorders should use caution.
• Exercise caution when driving or operating machinery.
• Regular medical monitoring may be required during long-term treatment.

Storage Instructions

• Store at room temperature below 25°C.
• Protect from moisture, heat, and direct sunlight.
• Keep tablets in the original container.
• Keep out of reach of children and pets.
• Do not use after the expiration date.

Related Healthcare Resources

Learn more about Parkinson’s disease management and neurological health in our
Healthcare Blog.

Need assistance with prescriptions, orders, or medication information? Visit our
Contact Us Page.

For official prescribing information and patient guidance, visit

MedlinePlus – Carbidopa and Levodopa Drug Information
.

Frequently Asked Questions (FAQs)

1. What does the CR designation mean in Carbidopa-Levodopa 25mg-100mg CR?

CR stands for Controlled Release. This formulation releases the medication gradually over time, helping maintain more consistent dopamine levels and longer-lasting symptom control.

2. What is Carbidopa-Levodopa 25mg-100mg CR used for?

It is primarily used to treat Parkinson’s disease and Parkinsonian syndromes, particularly in patients who require longer-lasting symptom management.

3. Can I crush or chew Carbidopa-Levodopa 25mg-100mg CR tablets?

No. Controlled-release tablets should generally be swallowed whole unless your healthcare provider specifically advises otherwise.

4. How is the controlled-release version different from immediate-release tablets?

Controlled-release tablets release medication slowly over time, while immediate-release tablets provide a faster onset but shorter duration of action.

5. Can Carbidopa-Levodopa 25mg-100mg CR cure Parkinson’s disease?

No. The medication does not cure Parkinson’s disease but helps manage symptoms and improve movement, mobility, and quality of life.

Medical Disclaimer

This content is provided for informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, changing, or discontinuing any medication. Carbidopa-Levodopa 25mg-100mg CR should be used only under the supervision of a qualified healthcare provider.